{"id":12297,"date":"2021-02-26T15:56:54","date_gmt":"2021-02-26T14:56:54","guid":{"rendered":"https:\/\/icfrc.fr\/?p=12297"},"modified":"2021-02-26T18:04:33","modified_gmt":"2021-02-26T17:04:33","slug":"dendritic-nanomaterials-for-the-early-diagnosis-of-cancer","status":"publish","type":"post","link":"https:\/\/fondation-lehn.fr\/en\/dendritic-nanomaterials-for-the-early-diagnosis-of-cancer\/","title":{"rendered":"Dendritic nanomaterials for the early diagnosis of cancer"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Startup Superbranche, a spin-off from the Institute of Physics and Chemistry of Materials (IPCMS) of Strasbourg was formed in May 2019 a\u017fter 10 years of R&D on hybrid nanomaterials and is positioning itself as a specialized producer of nanomaterials for nanomedicine. Superbranche is developing a new generation of functionalized metallic oxide nanoparticles that are designed to facilitate early diagnosis of and targeted therapy for cancer.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Current limits of nanoparticles used in oncology<\/h3>

Nanomedicine uses nanoparticles to better target tumor cells and limit side effects from chemotherapy. However, two major difficulties still need to be overcome: controlling the particle size so that they can be injected intravenously, and their \u201cvectorization.\u201d This is the ability to graft molecules of biological value that will enable nanoparticles to penetrate the target cells accurately. To overcome these two pitfalls, two Strasbourg researchers, Delphine Felder-Flesch<\/span>, research director at the Institute of Physics and Materials Science (IPCMS), and Sylvie Begin-Colin<\/span>, professor at the University of Strasbourg and director of the European School of Chemistry, Polymers and Materials (EPCM) propose using dendritic and magnetic nanoparticles. They founded the start-up Superbranche to commercialize these materials, the results of a ten-year research project.<\/p>

\u00a0<\/p>

\u00a0<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Startup Superbranche, a spin-off from the Institute of Physics and Chemistry of Materials (IPCMS) of Strasbourg<\/h3>

A spin-off from the IPCMS, Superbranche was formed in May 2019 after 10 years of R&D on hybrid nanomaterials used in the diagnosis and treatment of cancer. The Alsace Region, the Canc\u00e9ropole Grand Est, the University of Strasbourg, as well as the French National Agency for Research (ANR), the National Center for Scientific Research (CNRS) and the National Cancer Institute (INCA) and also the European Union, through its 2020 program, have invested $7 million in this new generation of nanomaterials.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Startup Superbranche, a spin-off from the Institute of Physics and Chemistry of Materials (IPCMS) of Strasbourg was formed in May 2019 a\u017fter 10 years of R&D on hybrid nanomaterials and is positioning itself as a specialized producer of nanomaterials for nanomedicine. Superbranche is developing a new generation of functionalized metallic oxide nanoparticles that are designed […]<\/p>\n","protected":false},"author":2,"featured_media":9894,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1,107],"tags":[],"acf":[],"yoast_head":"\nDendritic nanomaterials for the early diagnosis of cancer - Fondation Jean-Marie Lehn<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fondation-lehn.fr\/en\/dendritic-nanomaterials-for-the-early-diagnosis-of-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dendritic nanomaterials for the early diagnosis of cancer - Fondation Jean-Marie Lehn\" \/>\n<meta property=\"og:description\" content=\"Startup Superbranche, a spin-off from the Institute of Physics and Chemistry of Materials (IPCMS) of Strasbourg was formed in May 2019 a\u017fter 10 years of R&D on hybrid nanomaterials and is positioning itself as a specialized producer of nanomaterials for nanomedicine. Superbranche is developing a new generation of functionalized metallic oxide nanoparticles that are designed […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fondation-lehn.fr\/en\/dendritic-nanomaterials-for-the-early-diagnosis-of-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Fondation Jean-Marie Lehn\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Fondation-pour-la-Recherche-en-Chimie-244345315919500\/?fref=ts\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-26T14:56:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-02-26T17:04:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fondation-lehn.fr\/wp-content\/uploads\/2020\/11\/person-using-tablet-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1558\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Fondation_FRC\" \/>\n<meta name=\"twitter:site\" content=\"@Fondation_FRC\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\">\n\t<meta name=\"twitter:data1\" content=\"1 minute\">\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fondation-lehn.fr\/#website\",\"url\":\"https:\/\/fondation-lehn.fr\/\",\"name\":\"Fondation Jean-Marie Lehn\",\"description\":\"La Fondation accompagne le d\\u00e9veloppement du p\\u00f4le de recherche en chimie de l'Universit\\u00e9 de Strasbourg et du CNRS\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/fondation-lehn.fr\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/fondation-lehn.fr\/en\/dendritic-nanomaterials-for-the-early-diagnosis-of-cancer\/#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/fondation-lehn.fr\/wp-content\/uploads\/2020\/11\/person-using-tablet-scaled.jpg\",\"width\":2560,\"height\":1558,\"caption\":\"Person using tablet\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fondation-lehn.fr\/en\/dendritic-nanomaterials-for-the-early-diagnosis-of-cancer\/#webpage\",\"url\":\"https:\/\/fondation-lehn.fr\/en\/dendritic-nanomaterials-for-the-early-diagnosis-of-cancer\/\",\"name\":\"Dendritic nanomaterials for the early diagnosis of cancer - Fondation Jean-Marie Lehn\",\"isPartOf\":{\"@id\":\"https:\/\/fondation-lehn.fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/fondation-lehn.fr\/en\/dendritic-nanomaterials-for-the-early-diagnosis-of-cancer\/#primaryimage\"},\"datePublished\":\"2021-02-26T14:56:54+00:00\",\"dateModified\":\"2021-02-26T17:04:33+00:00\",\"author\":{\"@id\":\"https:\/\/fondation-lehn.fr\/#\/schema\/person\/d169037c171243ce645721a78f917f02\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fondation-lehn.fr\/en\/dendritic-nanomaterials-for-the-early-diagnosis-of-cancer\/\"]}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/fondation-lehn.fr\/#\/schema\/person\/d169037c171243ce645721a78f917f02\",\"name\":\"Fondation Jean-Marie Lehn\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/fondation-lehn.fr\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/85f77ee0d1520743c75986661e7a287e?s=96&d=mm&r=g\",\"caption\":\"Fondation Jean-Marie Lehn\"},\"sameAs\":[\"https:\/\/fondation-lehn.fr\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/fondation-lehn.fr\/en\/wp-json\/wp\/v2\/posts\/12297"}],"collection":[{"href":"https:\/\/fondation-lehn.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fondation-lehn.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fondation-lehn.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/fondation-lehn.fr\/en\/wp-json\/wp\/v2\/comments?post=12297"}],"version-history":[{"count":9,"href":"https:\/\/fondation-lehn.fr\/en\/wp-json\/wp\/v2\/posts\/12297\/revisions"}],"predecessor-version":[{"id":12326,"href":"https:\/\/fondation-lehn.fr\/en\/wp-json\/wp\/v2\/posts\/12297\/revisions\/12326"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fondation-lehn.fr\/en\/wp-json\/wp\/v2\/media\/9894"}],"wp:attachment":[{"href":"https:\/\/fondation-lehn.fr\/en\/wp-json\/wp\/v2\/media?parent=12297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fondation-lehn.fr\/en\/wp-json\/wp\/v2\/categories?post=12297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fondation-lehn.fr\/en\/wp-json\/wp\/v2\/tags?post=12297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}